Philips settles sleep apnea case with US justice, CEO enthusiastic about AI

Philips is nearing a resolution of its legal issues regarding faulty sleep apnea devices by agreeing to pay 288 million euros to U.S. authorities. This settlement, which has already been accounted for in their Q3 results, marks a significant step for the company, allowing it to refocus on innovation. Philips had previously recalled millions of devices in 2021 due to safety concerns. The company is now leveraging investments in AI to enhance medical equipment, improving efficiency in procedures like MRI scans. Despite a drop in profit, Philips reported growth in new orders and is set to receive 200 million euros from the U.S. government for overpaid import duties.